Skip to content

Hero image: A new mother speaking openly with a perinatal mental-health clinician while her partner supports her

All insights

Mind, Emotion and Family Wellness

Perinatal Depression: Screen Repeatedly, Respond Fully

11 min readEvidence synthesis
Read the evidence

The question in focus

A medical-grade guide to depression during pregnancy and the first postpartum year, including screening, urgent risk, prevention and integrated treatment.

Evidence at a glance

39% lower risk

of perinatal depression with counseling interventions among at-risk people in pooled trials

The USPSTF review pooled 17 trials and found a relative risk of 0.61. Most evidence concerned cognitive behavioral or interpersonal approaches in higher-risk populations, and small-study effects may overestimate benefit. [3]

Evidence Summary: Perinatal Depression Preventive Interventions

Perinatal depression can begin in pregnancy or after birth

Perinatal depression is a depressive disorder arising during pregnancy or in the first postpartum year. It can involve persistent low mood, loss of interest, guilt, hopelessness, irritability, impaired concentration, sleep or appetite change beyond infant-related disruption, difficulty bonding and thoughts of death. WHO reports that about 10% of pregnant women and 13% of women after birth experience a mental disorder, primarily depression, with higher burden in some settings. [4]

The baby blues are common, brief mood changes soon after birth. Persistent, severe or function-limiting symptoms require assessment. Depression can coexist with anxiety, obsessive-compulsive symptoms, trauma, substance use or bipolar disorder. A new parent's competence or love for the baby cannot be inferred from whether depression is present.

  • Ask about symptoms during pregnancy as well as postpartum.
  • Assess sleep opportunity separately from inability to sleep.
  • Include anxiety, trauma and obsessive thoughts.
  • Ask how symptoms affect care of self and baby.

Screening is a pathway, not a questionnaire

ACOG recommends standardized screening for depression and anxiety at the initial prenatal visit, later in pregnancy and at postpartum visits. [2] A positive screen is not a diagnosis. It should trigger clinical assessment of symptoms, duration, impairment, prior episodes, bipolar features, substance use, medical contributors and safety.

Screening without capacity to assess and treat can identify distress without helping it. Practices need a response protocol, referral network, emergency pathway and follow-up of missed connections. Language access, privacy, disability accommodation and the ability to answer without a partner present can change whether screening is meaningful.

  • Use a validated tool at repeated time points.
  • Assess every positive result clinically.
  • Screen for bipolar disorder before antidepressant monotherapy.
  • Track whether referral and treatment actually occurred.

Suicide and postpartum psychosis require immediate action

Every assessment should ask directly about suicidal thoughts, intent, plan, means, prior attempts and protective factors. Thoughts of harming the baby require careful, nonjudgmental assessment because unwanted intrusive thoughts can occur in anxiety or obsessive-compulsive disorder, while intent or psychosis signals a different level of emergency.

Postpartum psychosis may involve mania, severe confusion, delusions, hallucinations or rapidly changing behavior and is a psychiatric emergency. ACOG's diagnostic guideline specifically includes suicidality and acute postpartum psychosis. [1] The patient should not be left alone when immediate danger is present, and urgent local emergency services should be involved.

  • Ask about suicide directly.
  • Distinguish intrusive thoughts from intent through expert assessment.
  • Treat psychosis or mania as an emergency.
  • Create a documented safety and crisis plan.

Treatment balances illness risk, pregnancy and feeding goals

Psychotherapy, especially cognitive behavioral and interpersonal approaches, is effective for many people. Medication may be appropriate for moderate or severe depression, recurrence risk or inadequate response to therapy. NICE recommends choosing psychological and pharmacologic care according to severity, history, response, pregnancy stage and patient preference. [5]

Medication decisions should compare the known and uncertain risks of exposure with the risks of untreated illness, including impaired function, suicide risk and recurrence. Abruptly stopping an effective medicine can be harmful. Choice should consider prior response, bipolar risk, pregnancy, breastfeeding, infant health and access to monitoring, ideally with perinatal mental-health expertise for complex cases.

  • Do not stop psychiatric medicine abruptly without a plan.
  • Use prior effective treatment as important evidence.
  • Discuss absolute risks and uncertainty clearly.
  • Combine therapy, medicine and practical support when needed.

Prevention is possible for people at increased risk

The USPSTF recommends providing or referring pregnant and postpartum people at increased risk to counseling interventions. [3] Risk factors include a history of depression, current subthreshold symptoms, anxiety, low social support, intimate partner violence, adolescent or single parenthood, financial stress and major adverse events. No single risk tool identifies everyone who will benefit.

Pooled trials found benefit chiefly for cognitive behavioral and interpersonal programs, but most were small and conducted in higher-income settings. [3] Prevention should not substitute for treatment when depression is already present. It should be paired with practical support for sleep, safety, housing, food, violence and caregiving where those factors contribute to risk.

  • Offer preventive counseling before symptoms become severe.
  • Use history and social context, not one score alone.
  • Address intimate partner violence safely.
  • Escalate from prevention to treatment when diagnostic criteria are met.

Family and technology can support care, but neither replaces it

With consent, partners or family can learn warning signs, protect sleep, share infant care, support medication adherence and help implement the safety plan. They may also need assessment and support. Care should avoid assigning one family member as the sole clinical monitor or exposing the patient to an unsafe relationship. [1][5]

Teletherapy, secure messaging and remote screening can improve access, but passive smartphone sensing or consumer mood prediction is not a diagnostic replacement. Digital tools need clinical validation, crisis escalation, privacy safeguards and equitable non-digital alternatives. The strongest system integrates mental health into maternity and primary care so a positive screen leads to a known person, timely assessment and continued follow-up. [1][2][5]

  • Include support people only with permission and safety assessment.
  • Create protected sleep and practical-care plans.
  • Use digital tools only within a governed clinical pathway.
  • Continue follow-up through the first postpartum year.

What the evidence cannot yet answer

  • Global prevalence varies by diagnostic method, timing, culture, conflict, income and access to care.
  • Preventive counseling trials mainly involved higher-risk populations and many were small.
  • Medication evidence in pregnancy is largely observational because randomized exposure trials are often unethical.
  • A screening score cannot distinguish depression, bipolar disorder, psychosis, trauma and obsessive symptoms without clinical assessment.

Questions worth taking into care

  1. What will happen immediately if my screening result is positive?
  2. Have suicide risk, bipolar symptoms and postpartum psychosis been assessed?
  3. What are the risks of treatment and untreated illness in my situation?
  4. Could preventive counseling help given my history and current stressors?
  5. Who will follow me, and what is the crisis plan outside clinic hours?

Source record

Evidence used in this review

Sources were selected for clinical authority, methodological relevance and traceability. Links open the original guidance, public-health record or research publication.

  1. [1]
    Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum

    American College of Obstetricians and Gynecologists · 2023

  2. [2]
    Patient Screening for Perinatal Mental Health

    American College of Obstetricians and Gynecologists · 2025

  3. [3]
  4. [4]
    Perinatal Mental Health

    World Health Organization · 2025

  5. [5]
    Antenatal and Postnatal Mental Health: Clinical Management and Service Guidance

    National Institute for Health and Care Excellence · 2020

  6. [6]
Editorial standard

This evidence synthesis is for general information. It does not diagnose a condition or replace care from a qualified health professional. Treatment choices depend on individual history, examination, local guidance and informed preference. Emergency or rapidly worsening symptoms need urgent local medical assessment.